Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Tophaceous gout and renal insufficiency: a new solution for an old therapeutic dilemma.

Tausche AK, Wunderlich C, Aringer M.

Case Rep Med. 2011;2011:397646. doi: 10.1155/2011/397646. Epub 2011 May 14.

2.

Allopurinol for chronic gout.

Seth R, Kydd AS, Buchbinder R, Bombardier C, Edwards CJ.

Cochrane Database Syst Rev. 2014 Oct 14;(10):CD006077. doi: 10.1002/14651858.CD006077.pub3. Review.

PMID:
25314636
3.

Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.

Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A.

Arthritis Rheum. 2002 Aug;47(4):356-60.

4.
5.

Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol.

Richette P, Bardin T.

Nat Clin Pract Rheumatol. 2006 Jun;2(6):338-42; quiz 343.

PMID:
16932713
6.

Febuxostat: a new treatment for hyperuricaemia in gout.

Edwards NL.

Rheumatology (Oxford). 2009 May;48 Suppl 2:ii15-ii19. doi: 10.1093/rheumatology/kep088. Review.

PMID:
19447778
7.

Febuxostat for gout.

[No authors listed]

Drug Ther Bull. 2010 Jul;48(7):78-82. doi: 10.1136/dtb.2010.02.0017.

PMID:
20631196
8.
9.

Treatment of gout patients with impairment of renal function: a systematic literature review.

van Echteld IA, van Durme C, Falzon L, Landewé RB, van der Heijde DM, Aletaha D.

J Rheumatol Suppl. 2014 Sep;92:48-54. doi: 10.3899/jrheum.140462. Review.

PMID:
25180128
10.

Treatment of chronic gout in patients with renal function impairment: an open, randomized, actively controlled study.

Perez-Ruiz F, Calabozo M, Fernandez-Lopez MJ, Herrero-Beites A, Ruiz-Lucea E, Garcia-Erauskin G, Duruelo J, Alonso-Ruiz A.

J Clin Rheumatol. 1999 Apr;5(2):49-55.

PMID:
19078356
11.

Urate-lowering therapy for gout: focus on febuxostat.

Love BL, Barrons R, Veverka A, Snider KM.

Pharmacotherapy. 2010 Jun;30(6):594-608. doi: 10.1592/phco.30.6.594. Review.

PMID:
20500048
12.

Uricosuric medications for chronic gout.

Kydd AS, Seth R, Buchbinder R, Edwards CJ, Bombardier C.

Cochrane Database Syst Rev. 2014 Nov 14;(11):CD010457. doi: 10.1002/14651858.CD010457.pub2.

PMID:
25392987
13.

Benzbromarone therapy in management of refractory gout.

Kumar S, Ng J, Gow P.

N Z Med J. 2005 Jun 24;118(1217):U1528.

PMID:
15980902
14.

Pegloticase for treatment of tophaceous polyarticular gout.

Seifried RM, Roberts J.

Hawaii J Med Public Health. 2013 Jul;72(7):220-3.

15.

Febuxostat for treating chronic gout.

Tayar JH, Lopez-Olivo MA, Suarez-Almazor ME.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD008653. doi: 10.1002/14651858.CD008653.pub2. Review.

16.
17.

[Current opinions on gout, its diagnosis and treatment].

Němec P.

Vnitr Lek. 2012 Dec;58(12):928-37. Review. Czech.

PMID:
23427951
18.

Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis.

Borghi C, Perez-Ruiz F.

Eur Rev Med Pharmacol Sci. 2016 Mar;20(5):983-92. Review.

19.

Amputation of the first metatarsophalangeal joint due to a giant gouty tophi: A case report.

Zhou C, Xue C, Yang B, Wang W, Xu Y, Huang F, Wang Y.

Medicine (Baltimore). 2017 Oct;96(43):e8441. doi: 10.1097/MD.0000000000008441.

20.

Disease-related and all-cause health care costs of elderly patients with gout.

Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J, Krishnan E.

J Manag Care Pharm. 2008 Mar;14(2):164-75.

Supplemental Content

Support Center